Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
The current Eli Lilly(LLY) stock price is $1,064.37, with a market capitalization of 1.02T. The stock trades at a price-to-earnings (P/E) ratio of 53.24 and offers a dividend yield of 55.7%.
As of 2025-12-23, Eli Lilly(LLY) stock has fluctuated between $1,057.25 and $1,083.48. The current price stands at $1,064.37, placing the stock +0.7% above today's low and -1.8% off the high.
Eli Lilly(LLY) shares are trading with a volume of 2.63M, against a daily average of 3.8M.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
In the last year, Eli Lilly(LLY) shares hit a 52-week high of $1,111.99 and a 52-week low of $623.78.
LLY News
Before, they had to be injected, but now Novo Norkish has secured FDA approval for the oral version of its Wegovy weight-loss drug - beating its rival Eli Lilly...
Novo Nordisk (NVO) stock surged 9.5% in Monday’s extended trading session as the Danish drugmaker scored the U.S. Food and Drug Administration’s (FDA) approval...
Key Points New speculation arose about a potential buyout from a very deep-pocketed strategic investor. These first started to swirl in mid-December. 10 stoc...
Analyst ratings
77%
of 31 ratingsMore LLY News
Technology Novo Nordisk Jumps As FDA OKs Wegovy Pill As First-Ever Oral GLP-1 Weight Loss Drug Licensing The Food and Drug Administration approved a pill form o...
Abivax Société Anonyme (ABVX) shares jumped about 10% today after fresh media reports revived takeover speculation around the French biotech. French publication...
Novo Nordisk gained a head start in the GLP-1 race but then fell behind; Pfizer is working hard to catch up to the new leader. Shares of Novo Nordisk (NVO +1.0...
If you are wondering whether Eli Lilly is still worth buying after its massive run up, or if the market has already priced in all the good news, you are not alo...
Eli Lilly’s New Pill Keeps the Weight Off Eli Lilly said its experimental daily obesity pill helped patients maintain most of their weight loss after switching...
Below is Validea's guru fundamental report for ELI LILLY AND CO (LLY). Of the 22 guru strategies we follow, LLY rates highest using our Twin Momentum Investor m...
Analyst Jason Gerberry of Bank of America Securities reiterated a Buy rating on Eli Lilly & Co, retaining the price target of $1,268.00. Claim 50% Off TipRanks...